Palisade Capital Management’s Dermira, Inc. DERM Stock Holding History

Palisade Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,599	Closed	-$74K	–	436
2019 Q3	$74K	Buy	+11,599	New	+$96.8K	﹤0.01%	419
2018 Q3	–	Sell	-12,000	Closed	-$110K	–	480
2018 Q2	$110K	Buy	12,000 +1,000	+9%	+$9.32K	﹤0.01%	451
2018 Q1	$88K	Buy	+11,000	New	+$239K	﹤0.01%	438
2016 Q4	–	Sell	-99,215	Closed	-$3.35M	–	557
2016 Q3	$3.35M	Sell	99,215 -14,456	-13%	-$466K	0.12%	228
2016 Q2	$3.33M	Sell	113,671 -49,179	-30%	-$1.36M	0.12%	242
2016 Q1	$3.37M	Sell	162,850 -2,917	-2%	-$71.6K	0.11%	267
2015 Q4	$5.74M	Sell	165,767 -1,511	-0.9%	-$43.4K	0.19%	183
2015 Q3	$3.9M	Buy	+167,278	New	+$4.06M	0.12%	264

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Palisade Capital Management's DERM Position: Q4 2019 in Review

Palisade Capital Management sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 11,599 shares — an estimated $74K sold.

Palisade Capital Management first reported a position in DERM in Q3 2015 and held it in 8 quarters. The position peaked at $5.74M in Q4 2015. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

Palisade Capital Management reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
Palisade Capital Management sold 11,599 Dermira, Inc. shares in Q4 2019, an estimated $74K.
Palisade Capital Management first reported a position in Dermira, Inc. in Q3 2015 and held it in 8 quarters.
Palisade Capital Management's Dermira, Inc. position peaked at $5.74M in Q4 2015.
133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on Palisade Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.